Magle Chemoswed

Magle Chemoswed AB is a Sweden-based Contract Development and Manufacturing Organization (CDMO) specializing in the pharmaceutical and medical device industries. Tracing its roots to Chemoswed (1944) and Magle Life Sciences (1997), the company provides comprehensive services from product idea to manufacturing, leveraging its unique starch microsphere technology platform. Magle Chemoswed offers expertise in managing drug substances, biopharmaceuticals, and medical technology products, supported by a dedicated multi-disciplinary project management team. This team ensures seamless project execution, focusing on client needs, timelines, quantity, and quality throughout development. With approximately 70 employees, Magle Chemoswed delivers optimal solutions in analytical and process development, cGMP and ISO 13485 manufacturing, freeze-drying, and vial fill and finish services. Their robust quality assurance system and technical teams integrate regulatory and quality control requirements at every project milestone, ensuring efficacy, safety, and regulatory compliance for complex drug development projects, including specialized support for inhalation drug administration.